Abstract
In this issue of Blood, Badros et al bring the checkpoint inhibitor wave to multiple myeloma (MM), presenting clinical evidence supporting a role for T-cell–mediated immunity in controlling myeloma plasma cells.1.
Original language | English (US) |
---|---|
Pages (from-to) | 1175-1176 |
Number of pages | 2 |
Journal | Blood |
Volume | 130 |
Issue number | 10 |
DOIs |
|
State | Published - Sep 7 2017 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology